Sensome is a France-based startup specializing in Health Care and Medical Devices, founded in 2014. The company's innovative microsensing technology and predictive algorithms enable real-time tissue analysis during surgical procedures. Its proprietary Clotild® Smart Guidewire System, developed in collaboration with ASAHI INTECC, has applications in identifying cancerous lung tumors, characterizing clots in ischemic stroke, and peripheral vascular disease. Sensome's groundbreaking approach is based on electrical impedance spectroscopy, allowing for comprehensive tissue analysis. Their recent €8.00M Series B investment on January 12, 2020, attracted funding from leading investors such as IDInvest Partners, Kurma Partners, BNP Paribas Developpement, Asahi Intecc USA, Inc., and the Paris-Saclay Seed Fund. With its EN ISO 13485:2016 certification, Sensome is poised to make significant strides in revolutionizing intra-operative tissue analysis.
Sensome
Sensitive Medical Devices
France
39 employees
Series B
Total: $16.72M
Health Care, Medical Devices
General Information
France
BounceWatch is an independent company data service, not affiliated with Sensome. To contact Sensome, visit sensome.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Sensome compare?
A PDF of Sensome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Sensome soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
France Market
Health Care
About Sensome
Business keywords: Connected Objects, MedTech, Neurovascular, Remote Monitoring Technology, Vascular Access Devices, Implantable Devices, Electrical Impedance Spectroscopy, Predictive Algorithms, Ischemic Stroke, Peripheral Vascular Disease, Biological Tissue Analysis, Guidewire Technology, ISO 13485 Certification, Intra-operative Tissue Analysis
Services & Products
Target Customers
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | €8.00M | 5 |
|
12 Jan 2020 |
| Seed Round | €4.60M | 2 |
|
11 Jun 2018 |
| Seed Round | €3.00M | 3 |
|
10 Jul 2017 |
| Seed Round | €1.00M | 1 |
|
09 Nov 2015 |
| Pre Seed Round | €120.00K | 1 |
|
19 Feb 2015 |
| Venture Round | Undisclosed | 1 |
|
01 Sep 2014 |
Sensome Alternatives & Competitors
Real-time perfusion tracking in the angio suite. Accurate ischemic foot triage on the frontline.
FAQ About Sensome
Source: BounceWatch company record for Sensome, https://bouncewatch.com/company/sensome, updated 11 June 2025. When citing, please name BounceWatch and link this page.
